Loading…
Hosted by Tumori Journal · 🇺🇸 US · EN-US · 21 episodes
Established thought leaders with verified media credentials.
TJ Talks is an educational initiative featuring conversations about oncology led by Prof. Giancarlo Pruneri, Editor in Chief of Tumori Journal.The podcast series aims to explore a variety of topics of interest that reflect the dynamic and evolving nature of oncology research, with contributions from renowned international experts and promising young researchers in the field. Through these insightful discussions, TJ Talks seeks to support the professional development of clinicians and researchers working to improve the cancer care.Follow us on X, Bluesky and LinkedIn to always be updated on cancer research and clinical practice in oncology!
Tumori Journal hosts TJ Talks, a health show with 21 episodes published.
The BENCHISTA – International Benchmarking of Childhood Cancer Survival by Tumor stage – project is a worldwide collaboration led by University College London (UCL) and Fondazione IRCCS Istit
What emerges from the most recent first line trials is that the progress in advanced ovarian cancer depends not only on new treatment, but on the better patient selection: not all patients are in the same situation. And
Caught between enthusiasm for technical innovation and the need for a critical assessment of research practices, the oncology is seeking a new path that offers real hope for effective treatments and a fair distribution o
Imparare a governare l'innovazione: questo l'invito che il cosiddetto Common Sense Oncology rivolge alla comunità oncologica per un approccio terapeutico interamente centrato sui bisogni del paziente. Alla base del ragio
From advances in the screening of prostate cancer to the management of the genitourinary tumors, the GU oncology addresses ever more clinical challenges. What are the most relevant challenges in the management of the pro
The choice of an endpoint can really change the way a treatment is administered or approved for use on patients. And in the future, we will see much more data on quality of life, and trials will probably also work on val
Pharmaco-prevention of breast cancer is an evidence-based strategy that uses drugs to reduce the risk of disease in high-risk women. However, the use of this strategy remains modest due to concerns about toxicity, low aw
Stories of foreign cancer patients who ask to return to their country at the end of their lives: their deep desire to see their loved ones one last time is intertwined with medical, legal and financial issues that seem i
Storie di pazienti oncologici stranieri che chiedono di tornare nel loro Paese per il fine vita: attorno al desiderio profondo di rivedere ancora una volta i propri cari si intrecciano questioni mediche, legali, finanzia
Looking forward to the future, the trends and challenges regarding the increasing utilization of real-world data and single-arm trials in the oncology drug approval pathway by European Medicines Agency (EMA) is very impo
Le parole del prof. Paolo Marchetti restituiscono il quadro complesso dell’oncologia di precisione con il ritmo epico delle grandi imprese di frontiera. E’ lui - Professore Ordinario di Oncologia Medica dell’Università d
In this episode of TJ Talks, the guest is Professor Paolo Marchetti, a well-known expert in precision oncology in Italy, Full Professor of Medical Oncology at the University of Rome "La Sapienza", Scientific Director of
If we were to stop at a first glance, the use of liquid biopsy would be limited in the clinical practice of colorectal cancer to cases where tumour tissue is unavailable or insufficient. In reality, we are at the beginni
The field of bioinformatics is rapidly evolving, shaping the future of biomedical research and precision medicine. From cutting-edge advancements in computational biology to AI-driven solutions, what will the landscape l
Drug resistance is a major challenge in oncology and genetically-engineered mouse models represent powerful tools to identify new approaches for its overcoming. In this TJ Talks podcast, Prof Paola Perego, Pharmacology S
Dr. Arsela Prelaj is confident: the implementation of Artificial Intelligence in Oncology, in the near future, will be aimed at advances in screening and the use of images, such as radiomics; in digital pathology, for a
In this TJ Talks podcast, Dr Luca Agnelli, Tumori Journal Section Editor for Bioinformatics, meets Prof George Calin, a distinguished scientist with an extraordinary career dedicated to studying microRNAs, non-coding RNA
A scientific society for integrating all aspects of cancer care - diagnostics, pathology, surgery, radiation, and medical oncology -through a multidisciplinary approach, because the future of medical oncology will focus
Evidence suggests that dietary interventions can effectively delay, treat and even prevent certain illnesses. This leads to the hypothesis that metabolic interventions might aid cancer treatment, and this is the focus of
The role of pathologists in precision oncology is increasingly recognised as central to effective cancer diagnosis and treatment. Their expertise in tumor classification and biomarker identification is crucial for the de
Laura Botta
Fondazione IRCCS Istituto Nazionale dei Tumori
1 appearance on this show
Kathy Pritchard-Jones
University College London
1 appearance on this show
Francesco Perrone
Fondazione AIOM
1 appearance on this show
Massimo Di Maio
AIOM
1 appearance on this show
Gabriele Zoppoli
University of Genoa
1 appearance on this show
Erman Akkus
Ankara University
1 appearance on this show
Prof. Andrea De Censi
Champalimaud Foundation
1 appearance on this show
Prof. Antonino Musolino
IRCCS-Istituto Romagnolo per lo Studio dei Tumori “Dino Amadori”
1 appearance on this show
Dr Sergio Defendi
Asst Crema
1 appearance on this show
Dr Luca Zambelli
IRCCS National Cancer Institute Foundation
1 appearance on this show
Luca Zambelli
Fondazione IRCCS Istituto Nazionale dei Tumori di Milano
1 appearance on this show
Sergio Defendi
Asst Crema
1 appearance on this show
Sponsor detection runs nightly. Check back soon.
No public pitch examples yet for this show.
Generate your own personalised pitchBased on semantic analysis of episode topics and host coverage, this show is a strong guest fit for executives in:
Industry fit is computed by PitchCentric using vector embeddings of the show's episode catalog.
Shows with the most semantically similar episode content. Pitch one, pitch all; producers cluster.
TJ Talks has a verified contact on file. Create a free PitchCentric account to access it and generate a personalised pitch in seconds. Research at least 3 recent episodes first and lead with a specific angle that serves their health audience.
TJ Talks is hosted by Tumori Journal. The show is categorised under health (fitness) and has published 21 episodes.
TJ Talks has published 21 episodes.
TJ Talks regularly covers health, fitness, medicine. It sits in the health category, with a fitness focus.
TJ Talks is accessible for guests with genuine health expertise. A personalised, episode-aware pitch will still outperform a generic one every time.
TJ Talks hasn't explicitly signalled guest openness in recent episodes. That doesn't rule out pitching. your hook just needs to be especially compelling and relevant to their recent content.
Episodes of TJ Talks average 17 minutes. a focused format where a clear narrative arc and tight preparation matter most.
Our data rates TJ Talks's guest bar at 80/100 (Premium tier). Established thought leaders with verified media credentials. Sign in to PitchCentric to see how your own Pod Score compares against this show.
Methodology. Booking Probability™ blends Listen Score, 30-day Virality, open-to-guests detection, and Apple ratings. Data refreshed every 60 minutes. Listen Score and Booking Probability are calculated by PitchCentric. Last enriched 3 days ago.